BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bajaj JS, Lauridsen M, Tapper EB, Duarte-rojo A, Rahimi RS, Tandon P, Shawcross DL, Thabut D, Dhiman RK, Romero-gomez M, Sharma BC, Montagnese S. Important Unresolved Questions in the Management of Hepatic Encephalopathy: An ISHEN Consensus. Am J Gastroenterol 2020;115:989-1002. [DOI: 10.14309/ajg.0000000000000603] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Duong N, Reuter B, Saraireh H, Nadhem O, Acharya C, Fagan A, Hassouneh R, Bajaj JS. Bowel Movement Frequency Is Not Linked With Cognitive Function in Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00517-6. [PMID: 33991690 DOI: 10.1016/j.cgh.2021.05.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chapman B, Sinclair M, Gow PJ, Testro AG. Malnutrition in cirrhosis: More food for thought. World J Hepatol 2020; 12(11): 883-896 [PMID: 33312416 DOI: 10.4254/wjh.v12.i11.883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Gonzalez JJ, Tapper EB. A Prospective, Blinded Assessment of Ammonia Testing Demonstrates Low Utility Among Front-Line Clinicians. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00019-7. [PMID: 33453401 DOI: 10.1016/j.cgh.2021.01.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Huang Z, Yao Q, Zhu J, He Y, Chen Y, Wu F, Hua T. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPS) created using covered stents of different diameters: A systematic review and meta-analysis. Diagn Interv Imaging 2021;102:279-85. [PMID: 33303394 DOI: 10.1016/j.diii.2020.11.004] [Reference Citation Analysis]
5 Sanchez-Meza F, Torre A, Castillo-Martinez L, Sanchez-Roman S, Morales-Buenrostro LE. Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests. Ren Fail 2021;43:577-84. [PMID: 33757399 DOI: 10.1080/0886022X.2021.1901740] [Reference Citation Analysis]
6 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Reference Citation Analysis]
7 Basu E, Mehta M, Zhang C, Zhao C, Rosenblatt R, Tapper EB, Parikh NS. Association of chronic liver disease with cognition and brain volumes in two randomized controlled trial populations. J Neurol Sci 2021;434:120117. [PMID: 34959080 DOI: 10.1016/j.jns.2021.120117] [Reference Citation Analysis]
8 Miwa T, Hanai T, Toshihide M, Ogiso Y, Imai K, Suetsugu A, Takai K, Shiraki M, Katsumura N, Shimizu M. Zinc deficiency predicts overt hepatic encephalopathy and mortality in liver cirrhosis patients with minimal hepatic encephalopathy. Hepatol Res 2021;51:662-73. [PMID: 33242359 DOI: 10.1111/hepr.13601] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tapper EB, Zhao L, Nikirk S, Baki J, Parikh ND, Lok AS, Waljee AK. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis. Am J Gastroenterol 2020;115:2017-25. [PMID: 32773463 DOI: 10.14309/ajg.0000000000000762] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
10 Acharya C, Nadhem O, Shaw J, Hassouneh R, Fagan A, McGeorge S, Sterling RK, Puri P, Fuchs M, Luketic V, Sanyal AJ, Wade JB, Gilles HS, Heuman DM, Tinsley F, Matherly S, Lee H, Siddiqui MS, Thacker LR, Bajaj JS. Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis. Am J Gastroenterol 2021. [PMID: 34140445 DOI: 10.14309/ajg.0000000000001346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Bajaj JS. The Three Villages of Hepatic Encephalopathy. Am J Gastroenterol 2021;116:1184-6. [PMID: 33661145 DOI: 10.14309/ajg.0000000000001212] [Reference Citation Analysis]
12 Duong NK, Shrestha S, Park D, Shahab O, Fagan A, Malpaya Z, Gallagher ML, Morris A, Davis BC, Bajaj JS. Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis. Am J Gastroenterol 2021. [PMID: 34738545 DOI: 10.14309/ajg.0000000000001550] [Reference Citation Analysis]
13 Miwa T, Hanai T, Nishimura K, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shiraki M, Shimizu M. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis. JPEN J Parenter Enteral Nutr 2021. [PMID: 34287991 DOI: 10.1002/jpen.2222] [Reference Citation Analysis]
14 Tapper EB. A Trial of Ornithine Phenylacetate and the Arc of Ammonia's History in the Management of Overt Hepatic Encephalopathy. Clin Gastroenterol Hepatol 2021;19:2493-5. [PMID: 33157316 DOI: 10.1016/j.cgh.2020.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Gazda J, Drotar P, Drazilova S, Gazda J, Gazda M, Janicko M, Jarcuska P. Artificial Intelligence and Its Application to Minimal Hepatic Encephalopathy Diagnosis. J Pers Med 2021;11:1090. [PMID: 34834442 DOI: 10.3390/jpm11111090] [Reference Citation Analysis]
16 Hanai T, Shiraki M, Nishimura K, Miwa T, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shimizu M. Usefulness of the Stroop Test in Diagnosing Minimal Hepatic Encephalopathy and Predicting Overt Hepatic Encephalopathy. Hepatol Commun 2021;5:1518-26. [PMID: 34510827 DOI: 10.1002/hep4.1738] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Spyrogianni A, Gourmel C, Hofmann L, Marbach J, Leroux JC. Optimization of an ammonia assay based on transmembrane pH-gradient polymersomes. Sci Rep 2021;11:22032. [PMID: 34764318 DOI: 10.1038/s41598-021-01137-1] [Reference Citation Analysis]